Company / Working Capital per Share
ELITE PHARMACEUTICALS INC /NV/ Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.04
FY2025
5-year range
$0.01 / $0.04
FY2021-FY2025
Trend
+61.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has increased for 5 consecutive years, from $0.00 in FY2020 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of +85.5%.
Improved from $0.01 to $0.04 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +52.7%
- 5-Year CAGR
- +85.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- ELITE PHARMACEUTICALS INC /NV/'s working capital per share has grown for 5 consecutive years.
- In FY2025, working capital per share increased 61.6% year-over-year.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +61.6% |
| FY2024 | $0.03 | +96.6% |
| FY2023 | $0.01 | +12.2% |
| FY2022 | $0.01 | +58.8% |
| FY2021 | $0.01 | +288.6% |
| FY2020 | $0.00 | -19.6% |
| FY2019 | $0.00 | -73.7% |
| FY2018 | $0.01 | -56.3% |
| FY2017 | $0.02 | +10.7% |
| FY2016 | $0.02 | +47.6% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026